Janssen Publication and Patent Review Committee (2015-2023)
JLab core review committee and JLab expert consultant (JPal) (2015-2022)
Expert Consultant, Board of Science and Technology, Executive Yuan, Taiwan, R.O.C (2016-2020)
Committee member of the working group for miRNA standardization, Standards Development Organization, Singapore Manufacturing Federation, sponsored by Health Sciences Authority (2020)
Distinguished Alumni, National Tsing-Hua Univ. Taiwan (2015)
US NIH/NCI grant review committee for RFA-CA-13-015“Cancer Detection, Diagnostics, and Treatment Technologies for Global Health (UH2/UH3)”, NIH, US (2014)
Scientific Advisory Council, Genetic Analysis, Life Technologies (known today as ThermoFisher Scientific) (2012-2014)
Awards
Received 3 J&J Leadership awards (2022)
J&J“Ovation”Leadership Award (received $6000):“2021 PH DAS Renewal & Expansion Strategy”(2021)
Received 8 consecutive J&J Leadership Imperative“Applause”awards (awarded $1500 each) as core committee for Janssen Global Scientific Awards Review Committee (2015-2022)
J&J Leadership“Ovation”Award (awarded 3% base salary): Shape “Dx strategies”(2018)
Novartis:“2011 NIBR Team Award”for excellent science and teamwork on Everolimus (awarded $1000) (2011)
Received 4 Novartis Awards for oncology CDX programs and due diligence effort for M&A (2011)
Chiron:“Contribution Award”for successful regulatory filing and approval of Ultrio for HIV/HCV/HBV blood screening (2006);“Outstanding Performance” for exceeding program timelines (2005),“Inventor Recognition Award” (2004);“Outstanding Efforts”for accelerated HCV E1E2 vaccine Phase I/II IND (2001);“Exception Award”with $6500 for successful UK MCA filing and approval of Menjugate vaccine (1999)
